Regeneron Pharmaceuticals
REGN
#292
Rank
HK$511.04 B
Marketcap
HK$4,675
Share price
0.48%
Change (1 day)
-34.15%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): HK$292.58

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$289.79. In 2022 the company made an earnings per share (EPS) of HK$314.31 a decrease over its 2021 EPS that were of HK$593.01.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$292.58-6.91%
2022HK$314.31-47%
2021HK$593.01133.36%
2020HK$254.1169.13%
2019HK$150.25-14.44%
2018HK$175.61100.71%
2017HK$87.5031.78%
2016HK$66.4038.96%
2015HK$47.7872.55%
2014HK$27.69-17.55%
2013HK$33.59-44.98%
2012HK$61.05-422.54%
2011-HK$18.9392.13%
2010-HK$9.8549.41%
2009-HK$6.59-15.84%
2008-HK$7.83-36.88%
2007-HK$12.41-9.6%
2006-HK$13.734.12%
2005-HK$13.19-323.68%
2004HK$5.90-135.51%
2003-HK$16.60-24.38%
2002-HK$21.9556.35%
2001-HK$14.04187.3%
2000-HK$4.89-16%
1999-HK$5.82177.78%
1998-HK$2.09-35.71%
1997-HK$3.26-68.42%
1996-HK$10.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$109.76-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$31.88-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$143.19-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.26-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$29.01-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$24.67-91.49%๐Ÿ‡ซ๐Ÿ‡ท France